| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/10/2005 | US6891027 Composition for use in the modulation of immunological response |
| 05/10/2005 | US6891021 Regulated apoptosis |
| 05/10/2005 | US6891009 Water-soluble or water-swellable crosslinked copolymers |
| 05/10/2005 | US6890961 Applying topically to the leukoplakia lesion an effective amount of a clear aqueous formulation comprising: water; a water miscible polyol; unsaturated fatty acid ester; a surfactant, and beta -carotene |
| 05/10/2005 | US6890957 Liquid formulation of metformin |
| 05/10/2005 | US6890950 Complex with cyclodextrins; antitumor, anticancer agents |
| 05/10/2005 | US6890948 With an electron withdrawing substituent; Treating neoplastic diseases in methods of GDEPT, ADPET, PDEPT, VDEPT, and PDT; tissue-directed prodrug therapy |
| 05/10/2005 | US6890918 Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers |
| 05/10/2005 | US6890911 Method for the treatment of inflammation |
| 05/10/2005 | US6890901 Hyaluronic drug delivery system |
| 05/10/2005 | US6890897 In combination with an osteoinductive protein and a bone morphogenetic protein or a hedgehog protein to induce osteogenesis; biocompatible or biodegradable matrix |
| 05/10/2005 | US6890567 Sensate composition imparting initial sensation upon contact |
| 05/10/2005 | US6890560 Negatively charged amphiphilic block copolymer as drug carrier |
| 05/10/2005 | US6890559 Directly compressible raw material for tablets |
| 05/10/2005 | US6890557 A film forming emulsions comprising triglycerides, cholesterol, phospholipids, an charged lipid, and water; drug delivery with an apoprotein, deliverying nucleic acid, a gene therapy |
| 05/10/2005 | US6890545 Fungicide and method for producing the same |
| 05/10/2005 | US6890544 A formualtion for topical administration containing (a) a corticosteroid, and (b) a drying agent selected from calamine, zinc containing drying agents, copper sulfate, kaolin, potassium permanganate, silver nitrate, starch, talc |
| 05/10/2005 | US6890524 Hydrolyzable delivery system using cross-linked polymeric resins as vehicles |
| 05/10/2005 | US6890518 Compositions of chemically modified insulin |
| 05/10/2005 | US6890512 Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 05/10/2005 | CA2279743C Pharmaceutical composition of hedgehog proteins and use thereof |
| 05/10/2005 | CA2251987C Microparticles |
| 05/10/2005 | CA2232541C Fractionated vegetable oil |
| 05/10/2005 | CA2222995C Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 05/10/2005 | CA2183367C Ready-to-use indomethacin collyre |
| 05/10/2005 | CA2159353C Microcapsules with walls made of cross-linked plant polyphenols, and compositions containing same |
| 05/10/2005 | CA2153856C Duloxetine enteric pellets |
| 05/10/2005 | CA2116192C Highly concentrated tcf pharmaceutical preparations |
| 05/06/2005 | WO2005040382A2 Cherkasky fusion proteins containing antibody-, antigen- and microtubule-binding regions and immune response-triggering regions |
| 05/06/2005 | WO2005040365A1 Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein |
| 05/06/2005 | WO2005040353A2 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 05/06/2005 | WO2005040352A2 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 05/06/2005 | WO2005040349A2 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 05/06/2005 | WO2005040342A2 Cleavage of rna by restriction endonucleases |
| 05/06/2005 | WO2005040228A2 Disintegratable films for diagnostic devices |
| 05/06/2005 | WO2005040100A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | WO2005039641A2 Biomacromolecule polymer conjugates |
| 05/06/2005 | WO2005039620A1 Stable aqueous g-csf-containing compositions |
| 05/06/2005 | WO2005039616A1 Angiogenic peptides and uses thereof |
| 05/06/2005 | WO2005039605A1 Pharmaceutical composition comprising oxoplatin, the salts and derivatives thereof |
| 05/06/2005 | WO2005039602A1 Pharmacologically functional water and use thereof |
| 05/06/2005 | WO2005039558A1 Targeted delivery of therapeutically active compounds |
| 05/06/2005 | WO2005039553A1 Compositions for the treatment and prevention of cancer |
| 05/06/2005 | WO2005039552A2 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives |
| 05/06/2005 | WO2005039541A1 Coenzyme q10 enclosing capsule |
| 05/06/2005 | WO2005039532A1 Microemulsions of retinoids, and pharmaceutical compositions containing them |
| 05/06/2005 | WO2005039531A1 Transdermal pharmaceutical formulation for minimizing skin residues |
| 05/06/2005 | WO2005039525A1 Skin care and cleansing compositions containing oil seed product |
| 05/06/2005 | WO2005039501A2 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 05/06/2005 | WO2005039499A2 Rapidly disintegrating film |
| 05/06/2005 | WO2005039495A2 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 05/06/2005 | WO2005039464A1 Transdermal high and low molecular weight compounds |
| 05/06/2005 | WO2005027895A3 Thyroid hormone analogs and methods of use in angiogenesis |
| 05/06/2005 | WO2005023834A3 Peptides and compounds that bind to thrombopoietin receptors |
| 05/06/2005 | WO2005009436A8 Dispersible formulation of an anti-inflammatory agent |
| 05/06/2005 | WO2005003775A3 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 05/06/2005 | WO2005002626A8 Therapeutic phosphonate compounds |
| 05/06/2005 | WO2004112482A8 Biological active coating components, coatings, and coated surfaces |
| 05/06/2005 | WO2004105702A3 Foamable pharmaceutical compositions and methods for treating a disorder |
| 05/06/2005 | WO2004100994A3 Method for the production of a stable injectable formulation made of difficult to dissolve antineoplastic active substances |
| 05/06/2005 | WO2004091539A3 Fluid mixing methods and apparatus |
| 05/06/2005 | WO2004091537A3 Process for making gel films |
| 05/06/2005 | WO2004091495A3 Compositions and methods related to production of erythropoietin |
| 05/06/2005 | WO2004084807A3 Micro-cluster compositions |
| 05/06/2005 | WO2004081533A3 Vault and vault-like carrier molecules |
| 05/06/2005 | WO2004080383B1 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 05/06/2005 | WO2004078933A3 Intracellular delivery of small molecules proteins and nucleic acids |
| 05/06/2005 | WO2004062614A3 Carbohydrate conjugates to prevent abuse of controlled substances |
| 05/06/2005 | WO2004035537A8 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 05/06/2005 | WO2002095007A3 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 05/06/2005 | CA2543454A1 Drug-containing coated microparticles for quick-disintegrating oral tablets |
| 05/06/2005 | CA2542967A1 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives |
| 05/06/2005 | CA2542708A1 Dna delivery with gemini cationic surfactants |
| 05/06/2005 | CA2542494A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | CA2541511A1 Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein |
| 05/06/2005 | CA2541506A1 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 05/06/2005 | CA2541501A1 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 05/06/2005 | CA2541497A1 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 05/06/2005 | CA2541492A1 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 05/06/2005 | CA2540539A1 A mixture for transdermal delivery of low and high molecular weight compounds comprising an ethoxylated oil |
| 05/06/2005 | CA2539650A1 Skin care and cleansing compositions containing oil seed product |
| 05/05/2005 | US20050096479 Novel succinate salt of O-desmethyl-venlafaxine |
| 05/05/2005 | US20050096446 Tri-block copolymers and a process for the preparation of the same |
| 05/05/2005 | US20050096388 Compositions and methods for treating or preventing diseases of body passageways |
| 05/05/2005 | US20050096371 Topical pharmaceutical compositions |
| 05/05/2005 | US20050096365 Pharmaceutical compositions with synchronized solubilizer release |
| 05/05/2005 | US20050096340 lipophilic derivatives of paclitaxel, camptothecin, docetaxel or derivatives thereof; tocopherol succinate paclitaxel for example; emulsions for drug delivery, treating cancer; increased plasma elimination half-life compared to the parent therapeutic drug |
| 05/05/2005 | US20050096314 Treatment of cancers with methylol-containing compounds and at least one electrolyte |
| 05/05/2005 | US20050096298 Purine compounds for treatment of bone disorders or cancer |
| 05/05/2005 | US20050096296 Solubility of drugs is enhanced with solubilizers for drugs such as pioglitazone, zafilukast, simvastatin, atarvastin or fenofifrate |
| 05/05/2005 | US20050096287 Enhance delivery of oligonucleotides, nucleosides, nucleic acids by injection or applying on skin a solution in water |
| 05/05/2005 | US20050096284 RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA) |
| 05/05/2005 | US20050096277 Methods of prevention and treatment using apolipoprotein analogues |
| 05/05/2005 | US20050096261 Dna-binding polyamide drug conjugates |
| 05/05/2005 | US20050096254 Peptide deformylase activated prodrugs |
| 05/05/2005 | US20050095684 Protein fusion comprising colony stimulating factor activity for use as tool in rapid stimulation and production of white blood cells and neutrophils |
| 05/05/2005 | US20050095304 Composition and method for smoke detoxification |
| 05/05/2005 | US20050095298 Three dimensionally crosslinked agarose bead with grass pollen covalently bound; immunotherapy, vaccines, diagnosis |
| 05/05/2005 | US20050095297 Nanoparticulate formulations of fenofibrate |
| 05/05/2005 | US20050095293 Bioavailability of drug independent of gastric pH; core comprised of water soluble acid(s) of tartaric acid, fumaric acid, succinic acid, citric acid, malic acid, glutamic acid, and/or aspartic acid or salts; acid resistance; drug delivery |